Goodluck on CLBP. As long as you can afford to lose it (if you lose it, you may make a killing entirely possible).Goodluck on CLBP. Hopefully, my wish is that you become a little more critical if CLBP doesn't provide the results you want. You really want it to move toward FDA approval. But let's see what happens. However, when it doesn't turn out good then I hope rather than calling me a "downramper" you will rather jump on the bandwagon to hold management to be more accountable. That doesn't mean getting rid of SI or anyone but a little bit more use of professional scepticism when management talks.Look Goodluck honestly. Bio techs are risky but there are ways to reduce risks and manage expectations better than what Mesoblast has done. SI has been on record in 2015 saying to 2-3 years time stem cells will make enormous changes to medical treatment. Well that hasn't happened has it? Not one treatment in the US 5 years later. Anyway, let's not argue when CLBP isn't out yet, let's see that come thru and perhaps depending on that we can chat.
- Forums
- ASX - By Stock
- MSB
- MPC-06-ID Phase 3 results countdown
MPC-06-ID Phase 3 results countdown, page-266
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |